Literature DB >> 23015682

The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancer.

Florian Scotté1.   

Abstract

Optimal oncologic care of older men with prostate cancer, including effective prevention and management of the disease and treatment side effects (so-called best supportive care measures) can prolong survival, improve quality of life, and reduce depressive symptoms. In addition, the proportion of treatment discontinuations can be reduced through early reporting and management of side effects. Pharmacologic care may be offered to manage the side effects of androgen-deprivation therapy and chemotherapy, which may include hot flashes, febrile neutropenia, fatigue, and diarrhea. Nonpharmacologic care (e.g., physical exercise, acupuncture, relaxation) has also been shown to benefit patients. At the Georges Pompidou European Hospital, the Program of Optimization of Chemotherapy Administration has demonstrated that improved outpatient follow-up by supportive care measures can reduce the occurrence of chemotherapy-related side effects, reduce cancellations and modifications of treatment, reduce chemotherapy wastage, and reduce the length of stay in the outpatient unit. The importance of supportive care measures to optimize management and outcomes of older men with advanced prostate cancer should not be overlooked.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015682      PMCID: PMC3593780          DOI: 10.1634/theoncologist.2012-S1-23

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  43 in total

1.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors:  Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2006-05-08       Impact factor: 44.544

2.  An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women.

Authors:  H Dong; F Lüdicke; I Comte; A Campana; P Graff; P Bischof
Journal:  J Altern Complement Med       Date:  2001-12       Impact factor: 2.579

3.  Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancer.

Authors:  K Akakura; S Akimoto; J Shimazaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 4.  Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials.

Authors:  Ruud Knols; Neil K Aaronson; Daniel Uebelhart; Jaap Fransen; Geert Aufdemkampe
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

5.  EORTC elderly task force position paper: approach to the older cancer patient.

Authors:  A G Pallis; C Fortpied; U Wedding; M C Van Nes; B Penninckx; A Ring; D Lacombe; S Monfardini; P Scalliet; H Wildiers
Journal:  Eur J Cancer       Date:  2010-03-12       Impact factor: 9.162

6.  Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center.

Authors:  Michael A Kallen; James A Terrell; Paula Lewis-Patterson; Jessica P Hwang
Journal:  J Oncol Pract       Date:  2012-01       Impact factor: 3.840

7.  Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study.

Authors:  M Hammar; J Frisk; O Grimås; M Höök; A C Spetz; Y Wyon
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

Review 8.  Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Authors:  Jean-Pierre Droz; Lodovico Balducci; Michel Bolla; Mark Emberton; John M Fitzpatrick; Steven Joniau; Michael W Kattan; Silvio Monfardini; Judd W Moul; Arash Naeim; Hendrik van Poppel; Fred Saad; Cora N Sternberg
Journal:  Crit Rev Oncol Hematol       Date:  2010-01       Impact factor: 6.312

9.  Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer--a prospective multicenter study with long-term follow-up.

Authors:  Jessica Frisk; Anna-Clara Spetz; Hans Hjertberg; Bill Petersson; Mats Hammar
Journal:  Eur Urol       Date:  2008-02-14       Impact factor: 20.096

10.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Authors:  Ian F Tannock; Ronald de Wit; William R Berry; Jozsef Horti; Anna Pluzanska; Kim N Chi; Stephane Oudard; Christine Théodore; Nicholas D James; Ingela Turesson; Mark A Rosenthal; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

View more
  5 in total

Review 1.  Dermatologic Reactions to Targeted Therapy: A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care.

Authors:  Margaret Barton-Burke; Kathryn Ciccolini; Maria Mekas; Sean Burke
Journal:  Nurs Clin North Am       Date:  2017-03       Impact factor: 1.208

Review 2.  Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise.

Authors:  Semini Sumanasuriya; Johann De Bono
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

3.  Development of protocol for the management of cervical cancer symptoms in resource-constrained developing countries.

Authors:  Ramaiah Vinay Kumar; Suman Bhasker
Journal:  Support Care Cancer       Date:  2014-09-16       Impact factor: 3.603

4.  Multicentre prospective cohort study of unmet supportive care needs among patients with breast cancer throughout their cancer treatment trajectory in Penang: a PenBCNeeds Study protocol.

Authors:  Noorsuzana Mohd Shariff; Nizuwan Azman; Rohayu Hami; Noor Mastura Mohd Mujar; Mohammad Farris Iman Leong Bin Abdullah
Journal:  BMJ Open       Date:  2021-03-15       Impact factor: 2.692

5.  Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study.

Authors:  Philipp Zimmer; Elke Jäger; Wilhelm Bloch; Eva Maria Zopf; Freerk T Baumann
Journal:  BMC Cancer       Date:  2013-06-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.